Textextraktion: pypdf | Seiten: 4
1 Düsseldorf Local Division UPC_CFI_468/2024 Decision of the Court of First Instance of the Unified Patent Court issued on 11 April 2025 concerning EP 4 183 412 CLAIMANT: GlaxoSmithKline Biologicals SA, Rue de l’Institut 89, 1330 Rixensart, Belgium Represented by: Attorney at law Oliver Jan Jüngst, Attorney at law Luca Brons, Bird & Bird LLP, Carl-Theodor-Straße 6, 40213 Düsseldorf, Germany Participating: Patent Attorney Dr. Daniela Kinkeldey, Patent Attorney Dr. Anna Schadel, Bird & Bird LLP, Max imiliansplatz 22, 80333 Munich, Germany Electronic address for service: oliver.jan.juengst@twobirds.com DEFENDANTS: 1. Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Ixelles, Belgium 2. Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium 3. Pfizer Pharma GmbH, Friedrichstraß ...